Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
Koren
Gideon
G
Motherisk Program, The Hospital for Sick Children and University of Toronto, Toronto, Ont. gkoren@sickkids.ca
Matsui
Doreen
D
Einarson
Adrienne
A
Knoppert
David
D
Steiner
Meir
M
D000328:Adult; D003863:Depression / Q000188:drug therapy*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009357:Neonatal Abstinence Syndrome; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology*; D011263:Pregnancy Trimester, Third; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use
D017367:Selective Serotonin Reuptake Inhibitors